A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Dr. Alexandra Sowa, an obesity medicine specialist and author of the new book “The Ozempic Revolution ... medications for Americans with Medicare and Medicaid. A shortage in injections linked to ...
6d
Hosted on MSNInsurers push back on Medicare and Medicaid coverage for GLP-1sHealth plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results